Research in this U19 Program is dependent on a system of central, standardized, and innovative analyses of West Nile virus (WNV) infection in cultured cells and in mice. The Virology Core is designed to meet these needs and standards and to provide infrastructure support for conducting WNV infections and virologic analysis for all five research projects of the Program. The Virology Core will be directed by Dr. Yueh-Ming Loo, an experienced virologist, biosafety expert, and a professional in the use of mice for virus infection studies. The Virology core will 1) Produce, conduct quality control, and conduct studies of centralized virus stocks used by the Program, 2) Coordinate and conduct all mouse infection studies within the Program, 3) Conduct in vitro and in vivo virologic analyses for the Program, and 4) Conduct and coordinate biosafety training of the Program staff. The Virology Core will be located in a centralized facility containing a suite of biosafety rooms for tissue culture and infected animal housing under and work under biosafety level 3 practices. The Core will work closely with Project Leaders and staff to design infection studies and conduct virologic analysis in support of the proposed studies. The Core will provide services of virus and virus product quantification, virus construction and characterization, serologic analyses, molecular diagnostic and quantification analyses, in vitro and in vivo infection support and analysis, and animal monitoring, clinical scoring, and the harvesting and possessing of tissues and cell samples. The Virology Core will interface with the Administrative Core to maintain records and training of personnel, prepare reports, and to communicate with Program staff.
Reliable virologic analyses are essential for understanding mechanisms of immune control of virus infection. The Virology Core wills serve as the central and essential facility to conduct virologic and infection analyses within the proposed studies of the U19 Program, and will contribute to a greater understanding of flavivirus/host interactions that control infection and immunity.
|Walker, Christie L; Merriam, Audrey A; Ohuma, Eric O et al. (2018) Femur-sparing pattern of abnormal fetal growth in pregnant women from New York City after maternal Zika virus infection. Am J Obstet Gynecol 219:187.e1-187.e20|
|Hahn, William O; Butler, Noah S; Lindner, Scott E et al. (2018) cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses. JCI Insight 3:|
|Garber, Charise; Vasek, Michael J; Vollmer, Lauren L et al. (2018) Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1. Nat Immunol 19:151-161|
|Bowen, James R; Zimmerman, Matthew G; Suthar, Mehul S (2018) Taking the defensive: Immune control of Zika virus infection. Virus Res 254:21-26|
|Johnson, Britney; VanBlargan, Laura A; Xu, Wei et al. (2018) Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability. Immunity 48:487-499.e5|
|Aguilar-Valenzuela, Renan; Netland, Jason; Seo, Young-Jin et al. (2018) Dynamics of Tissue-Specific CD8+ T Cell Responses during West Nile Virus Infection. J Virol 92:|
|Platt, Derek J; Smith, Amber M; Arora, Nitin et al. (2018) Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice. Sci Transl Med 10:|
|Chow, Kwan T; Driscoll, Connor; Loo, Yueh-Ming et al. (2018) IRF5 regulates unique subset of genes in dendritic cells during West Nile virus infection. J Leukoc Biol :|
|Dudley, Dawn M; Van Rompay, Koen K; Coffey, Lark L et al. (2018) Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates. Nat Med 24:1104-1107|
|Pierson, Theodore C; Diamond, Michael S (2018) The emergence of Zika virus and its new clinical syndromes. Nature 560:573-581|
Showing the most recent 10 out of 147 publications